Showing results (61-70 of 79) with videos related to
Sort By:
Pageof 8
Cancer Gene Therapy|July 10, 2004
Use of the EGP-2/Ep-CAM promoter for targeted expression of heterologous genes in carcinoma derived cell linesPamela M J McLaughlin, Monika Trzpis, Bart-Jan Kroesen, et al.Molecular Cancer Therapeutics|July 2, 2014
EpCAM-selective elimination of carcinoma cells by a novel MAP-based cytolytic fusion proteinDmitrij Hristodorov, Manal Amoury, Radoslav Mladenov, et al.Cancer Letters|January 26, 2016
Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor modelManal Amoury, Katharina Kolberg, Anh-Tuan Pham, et al.Molecular Nutrition & Food Research|May 28, 2008
Human scFv SIgA expressed on Lactococcus lactis as a vector for the treatment of mucosal diseaseSaravanan Yuvaraj, Sa'ad Al-Lahham, Saed Lahham, et al.Cancer Research|September 26, 2014
Pretargeted dual-modality immuno-SPECT and near-infrared fluorescence imaging for image-guided surgery of prostate cancerSusanne Lütje, Mark Rijpkema, David M Goldenberg, et al.Nanomedicine (London, England)|May 29, 2012
In vitro and in vivo characterization of temoporfin-loaded PEGylated PLGA nanoparticles for use in photodynamic therapyMatija Rojnik, Petra Kocbek, Francesca Moret, et al.Mabs|March 12, 2015
C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicityValerie R Wiersma, Marco de Bruyn, Ce Shi, et al.Cancer Immunology, Immunotherapy : CII|August 1, 2007
Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion proteinJulia Stieglmaier, Edwin Bremer, Christian Kellner, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 31, 2021
Synthesis and Evaluation of 18F-Enzalutamide, a New Radioligand for PET Imaging of Androgen Receptors: A Comparison with 16β-18F-Fluoro-5α-DihydrotestosteroneInês F Antunes, Rutger J Dost, Hilde D Hoving, et al.EJNMMI Radiopharmacy and Chemistry|March 3, 2022
A proof-of-concept study on the use of a fluorescein-based 18F-tracer for pretargeted PETHugo Helbert, Emily M Ploeg, Douwe F Samplonius, et al.Pageof 8